India’s New Trade Deal Safeguards Generic Drug Industry, Rejects Patent Extensions and Data Exclusivity
India has reaffirmed its commitment to affordable medicines and public health safeguards in its latest Free Trade Agreement (FTA), signed on **July 24**. The government announced that the deal does **not include provisions** for **patent term extensions** or **data exclusivity**, commonly sought by multinational pharmaceutical companies to extend their market monopolies. The **Ministry of Commerce […]